Understanding MS
Click on the arrow icon <> and slide left and right to learn more about Multiple Sclerosis
Forms of MS at diagnosis
Course of the disease
Primary Progressive MS(PPMS)
PPMS is a debilitating form of the disease marked by steadily worsening symptoms, typically without distinct relapses or periods of remission. However, some people with PPMS do experience relapses. PPMS tends to be more disabling than RRMS. The accumulation of irreversible disability is twice as high in PPMS than in RRMS, which can mean people with PPMS rely more on mobility aids or wheelchairs.Relapsing-remitting MS (RRMS)
RRMS is characterised by episodes of new or worsening signs or symptoms (relapses) followed by periods of recovery (remission).The recovery between relapses may be complete or may leave lingering problems.Symptoms
Primary Progressive MS(PPMS)
The most commons symptoms in PPMS include progressive weakness, mobility issues and spasticity. These symptoms are not unique to PPMS but tend to be more persistent and difficult to manage.People may also have more problems thinking and speaking compared to people with RRMS.Relapsing-remitting MS (RRMS)
The most common symptoms in RRMS include episodic bouts of fatigue, numbness, vision problems, spasticity or stiffness, and bowel and bladder problems.Age at diagnosis
Primary Progressive MS(PPMS)
PPMS is usually diagnosed 10 years later than RRMS,5 after a steady decline in physical abilities can be identified and other diseases can be ruled out. This means diagnosis most often occurs in people in their 40s and 50s.Relapsing-remitting MS (RRMS)
RRMS is usually diagnosed when people are in their 20s and 30s.Ratio of men and women diagnosed
Disease activity
Unmet clinical need
Primary Progressive MS(PPMS)
PPMS is a highly disabling disease, therefore treatment should be based on clinical need and initiated as early as possible.Recent advances in the scientific understanding of MS have resulted in the development of new treatments that may slow disease progression in PPMS. There are no approved disease-modifying treatments for people with PPMS in many countries around the world, including Europe.
Relapsing-remitting MS (RRMS)
Despite available treatments, some people with RRMS continue to experience disease activity and worsening disability.Recent advances in the scientific understanding of MS have resulted in the development of treatments that may effectively slow disease progression in RRMS.